Latest Therapeutic Goods Administration News | Page 14

Company director sentenced to 2 years imprisonment with personal and company fines of over $ 2.5 million for selling illegal SARMs
Many young Australians exposed to e-cigarettes despite restrictions, study suggests
TGA Product Information safety updates 27 March
TGA review strengthens case for much tighter vape restrictions at the border
TGA’s new powers will help reduce the impact of medicine shortages on patients
Vaping law changes imminent
Covid vaccine safety report – 23-03-2023
Lapse of provisional registration for Tecentriq (atezolizumab) for the treatment of locally advanced or metastatic triple negative breast cancer (mTNBC)
Nubeqa registered by TGA for new patient group
Vaping increasing among young Aussies, as risks confirmed
New combination therapy for advanced prostate cancer secures TGA registration
GMP Clearance: Additional countries added to MRA pathway
Australia at risk of falling behind in prostate cancer
Calls for total elimination of direct sales of vaping products
Check for pholcodine use before general anaesthesia
JSHealth Vitamins fined $13,320 for alleged unlawful supply of a complementary medicine
Covid vaccine safety report – 09-03-2023
Australian manufacturer fined almost $160,000 for allegedly breaching conditions of its medicines manufacturing licence
TGA seizes more than 55,000 potentially dangerous products with the assistance of NSW Police
What has been achieved? ADA advocacy update for 2022
A potted history of smoking, and how we’re making the same mistakes with vaping
Sex and lies are used to sell vapes online. Even we were surprised at the marketing tactics we found
Reproductive health and safety always ahead of convenience, says AMA
TGA Product Information safety updates 2 March
Update on effectiveness of monoclonal antibodies against COVID variants
Training Our MRNA Manufacturing Workforce
Why cough medicines containing pholcodine can be deadly even if you took them months before surgery
Response to Pholcodine cough medicine recall
Consumers warned about Ozempic scams
Pholcodine cough medicines cancelled by the TGA and recalled from pharmacies for safety reasons
NSW pharmacy contraceptive trial shortcuts women’s health and safety
Covid vaccine safety report – 23-02-2023
Dr Joe Smith reappointed as chair of the Agricultural Biotechnology Council of Australia
TGA grants provisional approval to Moderna’s COVID-19 bivalent (SPIKEVAX Bivalent Original/Omicron BA.4-5) booster dose vaccine
Sport supplement suppliers to check products for latest WADA banned substances
DAEN – medicines update
Limited Ozempic supplies arriving soon at community pharmacies
Limited Ozempic supplies to commence distribution in Australia
New data shows Australians want action on e-cigarette crisis
What we can learn from the Ozempic shortage
Covid vaccine safety report – 09-02-23
Regrouping and rebuilding: ADA 2021-2022 Annual Report overview
ATAGI recommendations on use of Pfizer bivalent Covid vaccine 8 February
ATAGI 2023 booster advice
Avoid prescribing pregabalin in pregnancy if possible
The TGA has approved certain psychedelic treatments: the response from experts is mixed
Direction about advertisements: Melbourne-based individual
Monash Expert: TGA change to classification of psilocybin and MDMA